Recall Phenomenon After Intracranial Stereotactic Radiotherapy: Illustration of a Palpebral Reaction
Recall Phenomenon After Intracranial Stereotactic Radiotherapy: Illustration of a Palpebral Reaction
Katsumasa Nakamura1*, Tetsuo Nishimura2 and Kazuhiko Ogawa3
1Department of Radiation Oncology, Hamamatsu University Hospital, 1-20-1 Handayama, Higashi-ku, Hamamatsu-shi, Shizuoka, 431-3192, Japan
2Division of Radiation Oncology, Shizuoka Cancer Center Hospital, 1007 Shimonagakubo, Nagaizumi-cho, Sunto-gun, Shizuoka, 411-8777, Japan
3Department of Radiation Oncology, Osaka University Graduate School of Medicine, 2-2 Yamadaoka, Suita-shi, Osaka, 565- 0871, Japan
*Corresponding author: Katsumasa Nakamura, Department of Radiation Oncology, Hamamatsu University Hospital, 1-20-1 Handayama, Higashi-ku, Hamamatsu-shi, Shizuoka, 431-3192, Japan. E-mail: nakakatsuham19@gmail.com
Received: November 13, 2021; Accepted: November 22, 2021; Published:December 05, 2021
Citation: Nakamura K, Nishimura T, Ogawa K, et al. Recall Phenomenon After Intracranial Stereotactic Radiotherapy: Illustration of a Palpebral Reaction. Clin Image Case Rep J. 2021; 3(10): 197.
A 57-year-old woman, known for metastatic breast cancer, presented in November 2020 with a newly left intraorbital metastasis on MRI. The patient had a history of radiotherapy for focal leptomeningeal metastasis surrounding the area (left temporal), receiving 20 Gy in one fraction 7 months before. We irradiated this new metastasis delivering a fractionated stereotactic radiotherapy of 35 Gy in 7 fractions with a Cyberknife® system. The patient started a metronomic chemotherapy schema of Cyclophosphamide (50 mg daily) and Methotrexate (2.5 mg 2x/day) one week before the first day of radiotherapy. The day after the first fraction, she presented a severe left-eye palpebral edema.
Keywords: Stereotactic radiation; CyberKnife; Recall phenomenon; Eyelid edema
Comments
Post a Comment